Axonics shareholders approve $3.7B merger with Boston Sci (NASDAQ:AXNX)

Axonics (NASDAQ:AXNX) shareholders have permitted the corporate’s proposed merger take care of Boston Scientific (BSX).

The deal is predicted to shut within the first half of 2024, topic to sure circumstances together with ready intervals required underneath US and overseas antitrust legal guidelines.

Boston Scientific introduced in January that it had agreed to purchase the medical gadget maker for $71 in money, with the deal valued at round $3.7B.